Files size/type shown when available.
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
This solicitation is for Ustekinumab Pens/Syringes or a biosimilar, aimed at fulfilling the needs of the Department of Veterans Affairs. It is important for interested bidders to carefully assess their capabilities related to the production or supply of biological products within the specified NAICS code.
The buyer seeks to procure Ustekinumab Pens/Syringes or a biosimilar that meets regulatory standards and fulfills patient needs in the Veterans Affairs healthcare system.
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.
Awarded-market signal for NAICS 325412 (last 12 months), benchmarked to sector 32.
